Rainbow Thread Eyelid 30G/25, also known as Rainbow i, is a PDO lifting thread in a U-cannula specially designed for the eye area. The Eyelid Thread is targeted to sculpt and lift the area around the eyes as well as lift the eyebrows to give a more open and youthful appearance. The treatment is a non-surgical and minimally invasive procedure, which tightens the skin without the need of removing excess skin surgically.
The U-cannula allows optimal treatment without side effects and ensures minimized risk of bruising and swelling. Furthermore, the PDO Threads stimulates cell tissue activity and increase collagen formation, which supports the lifting effects and promotes elasticity for a natural look. Due to the properties of the Rainbow Eyelid Thread, this treatment is the perfect option for patients who wants to address the visible signs of ageing in order to gain a smoother and more youthful appearance, while rejuvenating the skin.
PDO Threads can be used alone or in combination with other treatments like fillers, PRP, or chemical peels.
The box consists of:
- 100 units (5 Pouches x 20 pcs)
Each pack contains:
- 30G x 25 mm needle
- PDO Suture sizes (USP): 6-0
Key ingredients:
- PDO (Polydioxanone)
Benefits of Rainbow Thread Eyelid 30G/25/30mm:
- Lifting effects
- Regenerate the skin cells and increase collagen
- No harmful effects to the body
- Immediate results
- Areas: Eye area, Eyebrow lifting
How long does the results last for?
Rainbow Thread Eyelid 30G/25/30 has immediate tissue repairing effects, which can last 2-3 years. The Eyelid PDO Threads dissolves naturally in the body and absorbs gradually into the dermis layer after approximately 6 months. After the PDO thread begins to dissolve, it helps to stimulate the production of collagen, which supports the lifting effect and significantly improves the skin texture around the eye.
The results depend on the patient’s age at the time of the treatment, the quality of the skin, the degree of sagging skin, and the number of used threads.
Reviews
There are no reviews yet.